Concordia's new CFO
"Edward J. Borkowski has held the title of Chief Financial Officer for a myriad of multi-billion dollar healthcare organizations such as Mylan, Inc. ($5.5B) (NASDAQ: MYL), Carefusion Corporation ($3.5B), ConvaTec ($1.7B) and Amerigen Pharmaceuticals, an early stage, private, generic pharmaceutical company. During Borkowski’s seven-year tenure at Mylan, he led the company from a $900 million revenue U.S.-based firm, to one of the world leaders in generic pharmaceuticals through a series of strategic acquisitions and internally focused development of new products; it is now $5.5 billion in revenue. At CareFusion Corporation, Borkowski was tasked with taking the company public in 2010. CareFusion is now a global $3.5 billion revenue healthcare company focused on pharmaceutical dispensing equipment, infusion pumps, ventilators and surgical instruments. Borkowski was acting CFO at ConvaTec through 2013. It is now is a $1.7 billion revenue global healthcare company, private-equity owned and focused on Ostomy, wound care, surgical dressings and urology and incontinence related products."
Only time will tell if he turns this ship around.